Arsenor

Arsenor is an oral formulation of Apremilast, a selective phosphodiesterase 4 (PDE4) inhibitor designed to provide effective and long-term management of chronic inflammatory conditions such as plaque psoriasis and psoriatic arthritis. Developed using high-quality raw materials and advanced pharmaceutical technology, Arsenor ensures Excellent therapeutic efficacy, safety, and enhanced patient adherence. 

Features